Exclusive Online Content
Ocean Biomedical, Inc. Celebrates 95% Lung Cancer Tumor Reduction Results on World Lung Cancer Day
On World Lung Cancer Day, Ocean Biomedical, Inc. is sharing details of its multi-pronged Lung Cancer Program built on novel immunotherapy discoveries by Scientific Co-founder Dr. Jack A. Elias. He and his team have revealed that Chitinase 3-like-1 (CHi3L1) is a master regulator that inhibits….
Mitsubishi Gas Chemical Develops First-Ever, PFAS-Free Oxygen Absorber to Help the Industry Meet Emerging Global Regulations
In response to the growing legislation around per- and polyfluoroalkyl substances (PFAS), Mitsubishi Gas Chemical (MGC) has launched the first future-proof, eco-friendly packaging solution for the industry using a cleaner chemistry within record-breaking turnaround…..
Bora Pharmaceuticals Unveils Eye-Opening New Facility for Ophthalmic Manufacturing
Bora Pharmaceuticals recently announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of….
First Wave BioPharma Announces Initial Topline Results From Phase 2 Trial Investigating Enhanced Adrulipase Formulation
First Wave BioPharma, Inc. recently announced it has received topline results from its Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic….
George Medicines Completes Recruitment of first Phase 3 Hypertension Trial Investigating Novel Single-Pill Triple Combination Candidate
George Medicines recently announced all patients have been enrolled in its Phase 3 active-controlled trial evaluating the efficacy and safety of GMRx2, the company’s….
Gerresheimer Launches Open Innovation Program for the Development of Home Therapy Solutions
As an innovative system and solution provider, Gerresheimer is the global partner for the pharma and biotech industry. In collaboration with ekipa, a leading incubator for open innovation, Gerresheimer is calling on start-ups, companies, students, researchers, and….
Kindeva Drug Delivery, Chiesi Group & H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production
Kindeva Drug Delivery and H&T Presspart are partnering with Chiesi Group for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Combining the specific….
Acquisition of Solus BioTech Expands Croda's Specialized Pharma Business in Asia
Croda International Plc recently announced it has acquired Solus BioTech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials…..
LIfT BioSciences Heralds a New Era of Affordable Effective Cancer Cell Therapies Simply Produced From iPSCs
LIfT BioSciences recently announced successful proof-of-concept production of its patented cancer killing alpha neutrophils from induced….
Caribou Biosciences Announces $25-Million Equity Investment From Pfizer
Caribou Biosciences, Inc. recently announced Pfizer Inc. has made a $25-million equity investment in the company. Pfizer purchased 4,690,431 of Caribou common shares at a price of….
Adare Pharma Solutions Announces Divestiture of Postbiotics Pioneer Adare Biome to dsm-firmenich
Adare Pharma Solutions recently announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, innovators in….
F-star Announces Strategic Collaboration & License Agreement With Takeda
F-star Therapeutics, an invoX company, recently announced it has entered into a strategic discovery collaboration and licensce agreement with….
Enterome Announces First Patient Dosed in Phase 1/2 Trial With Third OncoMimics Immunotherapy in Metastatic Colorectal Cancer
Enterome recently announced the first patient was dosed in the Phase 1/2 AUDREY trial evaluating EO4010, the company’s third OncoMimics candidate, for the treatment of patients with….
Ascendia Pharmaceuticals Develops Novel Nanoemulsion IV Formulation for Clopidogrel That Received IND Approval
Ascendia Pharmaceuticals CEO Jim Huang, PhD, recently announced Ascendia’s patented Emulsol® nanotechnology has been used to develop a novel nanoemulsion IV formulation for….
MoonLake Immunotherapeutics Achieves Landmark Milestone With Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa
MoonLake Immunotherapeutics recently announced positive top-line results from its global Phase 2 MIRA trial evaluating the efficacy and safety of the Nanobody sonelokimab in patients with moderate-to-severe….
Ocean Biomedical Announces US Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma) & Metastatic Melanoma
Patent broadens protection around Ocean Biomedical’s first-in-class anti-CHi3L1 antibody to include new bispecific approaches targeting immune checkpoints, with potential application in….
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Eli Lilly and Company and DICE Therapeutics, Inc. recently announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company that leverages its proprietary….
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation recently announced the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The license allows….
SCYNEXIS Announces Achievement of First Development Milestone of $25 Million Under Exclusive License Agreement With GSK
SCYNEXIS, Inc. recently announced the achievement of a $25-million performance-based development milestone under its exclusive license agreement with GSK for….
Croda Announces Two New Partnerships to Drive Sustainable Delivery Systems for the Pharmaceutical Industry
Croda International Plc recently announced it has signed two new partnership agreements that will help the pharmaceutical industry move toward a more sustainable supply chain for vaccine adjuvants…..
